TY  - GEN
AU  - Katsumi,Yoshiki
AU  - Kuwahara,Yasumichi
AU  - Tamura,Shinichi
AU  - Kikuchi,Ken
AU  - Otabe,Osamu
AU  - Tsuchiya,Kunihiko
AU  - Iehara,Tomoko
AU  - Kuroda,Hiroshi
AU  - Hosoi,Hajime
AU  - Sugimoto,Tohru
TI  - Trastuzumab activates allogeneic or autologous antibody-dependent cellular cytotoxicity against malignant rhabdoid tumor cells and interleukin-2 augments the cytotoxicity
SN  - 1078-0432
PY  - 2008///0603
KW  - Antibodies, Monoclonal
KW  - pharmacology
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibody-Dependent Cell Cytotoxicity
KW  - Antineoplastic Agents
KW  - Blotting, Western
KW  - Cell Line, Tumor
KW  - Female
KW  - Flow Cytometry
KW  - Fluorescent Antibody Technique
KW  - Humans
KW  - Immunohistochemistry
KW  - Infant
KW  - Infant, Newborn
KW  - Interleukin-2
KW  - Leukocytes, Mononuclear
KW  - immunology
KW  - Male
KW  - Receptor, ErbB-2
KW  - biosynthesis
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Rhabdoid Tumor
KW  - Trastuzumab
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-07-1661
ER  -